TRPV1 is part of the transient receptor potential family and is one of the non-GPCR cannabinoid receptors. TRPV1 is involved in thermoregulation and pain detection (nociception).

Hemopressin is a recently discovered endocannabinoid that acts as a CB1 inverse agonist (roughly meaning that it has the opposite action of THC at

PALDA is an endocannabinoid with weak CB1 affinity.

STEARDA is an endocannabinoid with weak CB1 affinity.

OLDA is an endocannabinoid that weakly binds CB1 and GPR119 but has high affinity for TRPV1.

Suspected endocannabinoid.

THCVA binds to several receptor (of the TRP class) but its exact physiological function is still under investigation.

CBGV interacts with several receptors and may have anti-inflammatory and analgesic properties but this is still under investigation.

CBGA is a precursor for the production of THC but has some therapeutic, anti-inflammatory, value as well. Given the number of receptor interactions CBGA is likely to have more therapeutic properties.